ar glp 1 GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease Gut Health at the Core GLP Glucagon-like peptide-1 receptor: mechanisms and

Trevaskis JL, Mack CM, Sun C, et al

These resources help you become an informed patient rather than a passive consumer, which leads to better conversations with your provider and better outcomes overall

Setting realistic expectations and maintaining consistent lifestyle habits are key factors in achieving sustainable weight loss

This includes joint and muscle aches, fluid retention

Your current weight, overall health, prior attempts at weight loss, and Body Mass Index (BMI) are all factors we consider when discussing weight-loss medication options

Both Novo Nordisk, the maker of Wegovy, and Eli Lilly, the maker of Zepbound, say there will continue to be shortages but they plan to continue to increase overall supply